vs
PennyMac Financial Services, Inc.（PFSI）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是PennyMac Financial Services, Inc.的1.2倍（$622.0M vs $538.0M），PennyMac Financial Services, Inc.净利率更高（1752.5% vs 34.4%，领先1718.0%），PennyMac Financial Services, Inc.同比增速更快（14.4% vs 4.8%），过去两年PennyMac Financial Services, Inc.的营收复合增速更高（32.7% vs 4.6%）
PennyMac Financial Services是总部位于美国加利福尼亚州西湖村的住宅抵押贷款企业，核心业务涵盖美国抵押贷款的发放、贷后服务，以及抵押贷款市场相关投资管理。公司下设两家子公司，其中PNMAC资本管理有限公司负责运营旗下的抵押贷款不动产投资信托（REIT）PennyMac Mortgage Investment Trust。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PFSI vs RPRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $538.0M | $622.0M |
| 净利润 | $106.8M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 25.0% | 62.4% |
| 净利率 | 1752.5% | 34.4% |
| 营收同比 | 14.4% | 4.8% |
| 净利润同比 | 2.2% | 2.9% |
| 每股收益（稀释后） | $1.97 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $538.0M | $622.0M | ||
| Q3 25 | $632.9M | $609.3M | ||
| Q2 25 | $444.7M | $578.7M | ||
| Q1 25 | $430.9M | $568.2M | ||
| Q4 24 | $470.1M | $593.6M | ||
| Q3 24 | $411.8M | $564.7M | ||
| Q2 24 | $406.1M | $537.3M | ||
| Q1 24 | $305.7M | $568.0M |
| Q4 25 | $106.8M | $214.2M | ||
| Q3 25 | $181.5M | $288.2M | ||
| Q2 25 | $136.5M | $30.2M | ||
| Q1 25 | $76.3M | $238.3M | ||
| Q4 24 | $104.5M | $208.2M | ||
| Q3 24 | $69.4M | $544.0M | ||
| Q2 24 | $98.3M | $102.0M | ||
| Q1 24 | $39.3M | $4.8M |
| Q4 25 | 25.0% | 62.4% | ||
| Q3 25 | 37.3% | 70.1% | ||
| Q2 25 | 17.2% | 36.3% | ||
| Q1 25 | 24.2% | 94.0% | ||
| Q4 24 | 27.5% | 60.9% | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 33.0% | 50.2% | ||
| Q1 24 | 14.4% | -13.0% |
| Q4 25 | 1752.5% | 34.4% | ||
| Q3 25 | 28.7% | 47.3% | ||
| Q2 25 | 30.7% | 5.2% | ||
| Q1 25 | 17.7% | 41.9% | ||
| Q4 24 | 2559.8% | 35.1% | ||
| Q3 24 | 16.8% | 96.3% | ||
| Q2 24 | 24.2% | 19.0% | ||
| Q1 24 | 12.9% | 0.8% |
| Q4 25 | $1.97 | $0.49 | ||
| Q3 25 | $3.37 | $0.67 | ||
| Q2 25 | $2.54 | $0.07 | ||
| Q1 25 | $1.42 | $0.55 | ||
| Q4 24 | $1.95 | $0.46 | ||
| Q3 24 | $1.30 | $1.21 | ||
| Q2 24 | $1.85 | $0.23 | ||
| Q1 24 | $0.74 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $410.0M | $618.7M |
| 总债务越低越好 | $6.2B | $9.0B |
| 股东权益账面价值 | $4.3B | $9.7B |
| 总资产 | $29.4B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.45× | 0.92× |
8季度趋势，按日历期对齐
| Q4 25 | $410.0M | $618.7M | ||
| Q3 25 | $62.2M | $938.9M | ||
| Q2 25 | $462.3M | $631.9M | ||
| Q1 25 | $443.4M | $1.1B | ||
| Q4 24 | $420.6M | $929.0M | ||
| Q3 24 | $667.9M | $950.1M | ||
| Q2 24 | $188.8M | $1.8B | ||
| Q1 24 | $69.0K | $843.0M |
| Q4 25 | $6.2B | $9.0B | ||
| Q3 25 | $6.2B | $8.9B | ||
| Q2 25 | $5.6B | $8.0B | ||
| Q1 25 | $5.8B | $7.6B | ||
| Q4 24 | $5.3B | $7.6B | ||
| Q3 24 | $4.9B | $7.6B | ||
| Q2 24 | $4.9B | $7.6B | ||
| Q1 24 | $4.5B | $6.1B |
| Q4 25 | $4.3B | $9.7B | ||
| Q3 25 | $4.2B | $9.6B | ||
| Q2 25 | $4.0B | $9.5B | ||
| Q1 25 | $3.9B | $9.8B | ||
| Q4 24 | $3.8B | $10.3B | ||
| Q3 24 | $3.7B | $10.3B | ||
| Q2 24 | $3.7B | $9.8B | ||
| Q1 24 | $3.6B | $9.9B |
| Q4 25 | $29.4B | $19.6B | ||
| Q3 25 | $25.4B | $19.3B | ||
| Q2 25 | $24.2B | $18.3B | ||
| Q1 25 | $23.9B | $17.6B | ||
| Q4 24 | $26.1B | $18.2B | ||
| Q3 24 | $22.9B | $18.0B | ||
| Q2 24 | $21.6B | $17.7B | ||
| Q1 24 | $19.8B | $16.1B |
| Q4 25 | 1.45× | 0.92× | ||
| Q3 25 | 1.48× | 0.93× | ||
| Q2 25 | 1.38× | 0.84× | ||
| Q1 25 | 1.48× | 0.78× | ||
| Q4 24 | 1.37× | 0.74× | ||
| Q3 24 | 1.32× | 0.74× | ||
| Q2 24 | 1.35× | 0.78× | ||
| Q1 24 | 1.27× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.7B | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.7B | — |
| 自由现金流率自由现金流/营收 | -309.3% | — |
| 资本支出强度资本支出/营收 | 2.2% | — |
| 现金转化率经营现金流/净利润 | -15.46× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-1.4B | — |
8季度趋势，按日历期对齐
| Q4 25 | $-1.7B | $827.1M | ||
| Q3 25 | $-697.4M | $702.6M | ||
| Q2 25 | $-131.3M | $364.0M | ||
| Q1 25 | $1.1B | $596.1M | ||
| Q4 24 | $-4.5B | $742.5M | ||
| Q3 24 | $-393.7M | $703.6M | ||
| Q2 24 | $-1.1B | $658.2M | ||
| Q1 24 | $-897.9M | $664.6M |
| Q4 25 | $-1.7B | — | ||
| Q3 25 | $-699.4M | — | ||
| Q2 25 | $-132.6M | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $-4.5B | — | ||
| Q3 24 | $-393.9M | — | ||
| Q2 24 | $-1.1B | — | ||
| Q1 24 | $-898.9M | — |
| Q4 25 | -309.3% | — | ||
| Q3 25 | -110.5% | — | ||
| Q2 25 | -29.8% | — | ||
| Q1 25 | 247.3% | — | ||
| Q4 24 | -964.7% | — | ||
| Q3 24 | -95.6% | — | ||
| Q2 24 | -269.2% | — | ||
| Q1 24 | -294.1% | — |
| Q4 25 | 2.2% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | -15.46× | 3.86× | ||
| Q3 25 | -3.84× | 2.44× | ||
| Q2 25 | -0.96× | 12.06× | ||
| Q1 25 | 13.97× | 2.50× | ||
| Q4 24 | -43.39× | 3.57× | ||
| Q3 24 | -5.68× | 1.29× | ||
| Q2 24 | -11.12× | 6.45× | ||
| Q1 24 | -22.84× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PFSI
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
